0001708138-20-000052.txt : 20200508
0001708138-20-000052.hdr.sgml : 20200508
20200508160413
ACCESSION NUMBER: 0001708138-20-000052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200506
FILED AS OF DATE: 20200508
DATE AS OF CHANGE: 20200508
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Van Plew Daniel P
CENTRAL INDEX KEY: 0001411984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19034
FILM NUMBER: 20860495
MAIL ADDRESS:
STREET 1: REGENERON PHARMACEUTICALS, INC.
STREET 2: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC.
CENTRAL INDEX KEY: 0000872589
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133444607
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
BUSINESS PHONE: 9148477000
MAIL ADDRESS:
STREET 1: 777 OLD SAW MILL RIVER ROAD
CITY: TARRYTOWN
STATE: NY
ZIP: 10591
FORMER COMPANY:
FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930328
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-05-06
0
0000872589
REGENERON PHARMACEUTICALS, INC.
REGN
0001411984
Van Plew Daniel P
777 OLD SAW MILL RIVER ROAD
TARRYTOWN
NY
10591
0
1
0
0
EVP & General Mgr Industrial O
Common Stock
2020-05-06
4
M
0
33079
52.03
A
61330
D
Common Stock
2020-05-06
4
F
0
17779
555.77
D
43551
D
Common Stock
2020-05-06
4
M
0
52500
52.03
A
96051
D
Common Stock
2020-05-06
4
F
0
28217
555.77
D
67834
D
Common Stock
2020-05-07
4
S
0
100
556.92
D
67734
D
Common Stock
2020-05-07
4
S
0
600
557.59
D
67134
D
Common Stock
2020-05-07
4
S
0
2118
558.43
D
65016
D
Common Stock
2020-05-07
4
S
0
500
559.2
D
64516
D
Common Stock
2020-05-07
4
S
0
3231
560.53
D
61285
D
Common Stock
2020-05-07
4
S
0
4988
561.55
D
56297
D
Common Stock
2020-05-07
4
S
0
2077
562.45
D
54220
D
Common Stock
2020-05-07
4
S
0
2195
563.58
D
52025
D
Common Stock
2020-05-07
4
S
0
3000
564.54
D
49025
D
Common Stock
2020-05-07
4
S
0
5984
565.49
D
43041
D
Common Stock
2020-05-07
4
S
0
7297
566.47
D
35744
D
Common Stock
2020-05-07
4
S
0
3753
567.35
D
31991
D
Common Stock
2020-05-07
4
S
0
3040
568.57
D
28951
D
Common Stock
2020-05-07
4
S
0
700
569.42
D
28251
D
Common Stock
1561
I
By 401(k) Plan
Non-Qualified Stock Option (right to buy)
52.03
2020-05-06
4
M
0
33079
0.0
D
2021-12-16
Common Stock
33079
52500
D
Non-Qualified Stock Option (right to buy)
52.03
2020-05-06
4
M
0
52500
0.0
D
2021-12-16
Common Stock
52500
0
D
Represents volume-weighted average price of sales of 600 shares of Company stock on May 7, 2020 at prices ranging from $557.13 to $557.89. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,118 shares of Company stock on May 7, 2020 at prices ranging from $558.02 to $558.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 500 shares of Company stock on May 7, 2020 at prices ranging from $559.05 to $559.36. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,231 shares of Company stock on May 7, 2020 at prices ranging from $560.00 to $560.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 4,988 shares of Company stock on May 7, 2020 at prices ranging from $561.00 to $561.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,077 shares of Company stock on May 7, 2020 at prices ranging from $562.03 to $562.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 2,195 shares of Company stock on May 7, 2020 at prices ranging from $563.00 to $563.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,000 shares of Company stock on May 7, 2020 at prices ranging from $564.04 to $564.92. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 5,984 shares of Company stock on May 7, 2020 at prices ranging from $565.03 to $565.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 7,297 shares of Company stock on May 7, 2020 at prices ranging from $566.00 to $566.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,753 shares of Company stock on May 7, 2020 at prices ranging from $567.00 to $567.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 3,040 shares of Company stock on May 7, 2020 at prices ranging from $568.10 to $568.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
Represents volume-weighted average price of sales of 700 shares of Company stock on May 7, 2020 at prices ranging from $569.02 to $569.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 7, 2020 at each separate price.
With respect to 33,079 underlying shares (of which 0 remain outstanding), the stock option award vested in four equal annual installments, commencing one year after the date of grant. With respect to 52,500 underlying shares (of which 0 remain outstanding), the option became exercisable on December 31, 2014, based upon the satisfaction by the company of certain performance criteria during the period ended December 31, 2014.
/s/**Daniel P. Van Plew
2020-05-08